文献速递艾滋病与性传播感染结核与非结核分枝杆菌

人类免疫缺陷病毒合并结核感染患者的循环生物标志物、呼出气一氧化氮分数与肺功能

Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis.
PubMed 文献 · J Infect Dis · 2024-01-01

南非一项前瞻性队列纳入105例新诊断结核合并人类免疫缺陷病毒(HIV)的成人,自抗逆转录病毒治疗(ART)启动起随访48周,系列评估血浆生物标志物、呼出气一氧化氮分数(FeNO)、肺功能和呼吸症状。基线时较高FeNO与较好的肺功能相关,呼吸症状较多和较高白介素(IL)-6与较差的肺功能相关;ART和结核治疗后肺功能改善与FeNO升高及IL-6、血管内皮生长因子(VEGF)下降相关。

要点

  • 基线较高FeNO与较好肺功能相关,症状较多及IL-6较高与较差肺功能相关
  • 治疗后肺功能改善与FeNO升高、IL-6和VEGF下降相关
  • 循环IL-6、VEGF和FeNO可能与结核/HIV治疗成人肺功能相关

核心结论

  • 循环IL-6、VEGF和FeNO与正在接受结核/HIV治疗的成人肺功能相关。
  • 这些生物标志物可能有助于识别结核后肺病风险较高的个体,并阐明可干预的通路以改变结核存活者慢性肺损伤的风险。

研究设计与样本

  • 前瞻性队列研究,纳入南非105例新诊断结核合并HIV的成人。
  • 自ART启动起随访48周,系列评估血浆生物标志物、FeNO、肺功能和呼吸症状。
  • 采用线性回归和广义估计方程分别分析基线和结核治疗过程中的关联。

主要发现

  • 基线时,较高FeNO水平与较好的肺功能相关。
  • 基线时,呼吸症状较多和血浆IL-6水平较高与较差的肺功能相关。
  • ART和结核治疗启动后,肺功能改善与FeNO升高相关(率比[RR]=86 mL,95%置信区间[CI]=34-139)。
  • 治疗后肺功能改善与IL-6下降相关(RR=-118 mL,95%CI=-193至-43)。
  • 治疗后肺功能改善与VEGF下降相关(RR=-178 mL,95%CI=-314至-43)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identification of proinflammatory factors responding to Mycobacterium tuberculosis is important to reduce long-term sequelae of pulmonary tuberculosis (TB). METHODS: We examined the association between plasma biomarkers, the fraction of exhaled nitric oxide (FeNO), and lung function among a prospective cohort of 105 adults newly diagnosed with TB/human immunodeficiency virus (HIV) in South Africa. Participants were followed for 48 weeks from antiretroviral therapy (ART) initiation with serial assessments of plasma biomarkers, FeNO, lung function, and respiratory symptoms. Linear regression and generalized estimating equations were used to examine the associations at baseline and over the course of TB treatment, respectively. RESULTS: At baseline, higher FeNO levels were associated with preserved lung function, whereas greater respiratory symptoms and higher interleukin (IL)-6 plasma levels were associated with worse lung function. After ART and TB treatment initiation, improvements in lung function were associated with increases in FeNO (rate ratio [RR] = 86 mL, 95% confidence interval [CI] = 34-139) and decreases in IL-6 (RR = -118 mL, 95% CI = -193 to -43) and vascular endothelial growth factor ([VEGF] RR = -178 mL, 95% CI = -314 to -43). CONCLUSIONS: Circulating IL-6, VEGF, and FeNO are associated with lung function in adults being treated for TB/HIV. These biomarkers may help identify individuals at higher risk for post-TB lung disease and elucidate targetable pathways to modify the risk of chronic lung impairment among TB survivors.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Maenetje P, Baik Y, Schramm DB, et al. Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis. J Infect Dis. 2024. PMID: 37386883. doi:10.1093/infdis/jiad232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。